# NCT07832292 (NCT07832292)

> A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT07832292
- Phase: PHASE2
- Status: RECRUITING
- Sponsor: Janssen Research & Development, LLC
- Conditions: Prostatic Neoplasms
- Interventions: JNJ-101556143
- Enrollment: 100
- Primary outcome: Overall Response Rate (ORR)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct07832292